Melanoma Spotlight

Melanoma Spotlight
Melanoma is the deadliest form of skin cancer, accounting for the majority of skin cancer deaths worldwide. 

While melanoma rates have been rising over the last 30 years, advancements in treatment and early detection are providing new hope for patients everywhere. In this edition of Guided By Science, we explore melanoma prevention, early detection, and new treatments that are changing the way we treat this deadly disease.

Metastasis: How does Cancer Spread?

While people often talk about types of cancer as though they are all the same, it really couldn’t be further from the truth. Not only are different cancer types very diverse but also each individual type can have their own subtypes, along with different phases the cancer itself can be in. These phases are loosely based on how far the cancer has spread from the original site. The spread of cancer to other types of the body is known as metastasis.

ImmunoPulse Clinical Progress with Tu Diep of OncoSec Medical

Recently, we filmed a clinical progress video discussing details of our ImmunoPulse therapy and results with Tu Diep: OncoSec’s executive director of clinical development. With over a decade of experience in clinical research, prior to joining OncoSec – including Protox Therapeutics Inc. (now Sophiris Bio Inc.) – Mr. Diep’s experience has been a large asset to our company.

PD-1 and OncoSec’s Combination Study

There has been a lot of attention surrounding the effectiveness of PD-1 drugs lately. The New York Times published an article recently on how such drugs are “unleashing the immune system to attack cancer cells…” and that this “could be an alternative to often-debilitating chemotherapy.”

Avoiding Skin Cancer

While skin cancer is often caused by UV radiation (around 90% of non-melanoma skin cancers being caused by it), you’re never too old or too tanned to start avoiding skin cancer. Genetic damage in the skin caused by sun exposure permanently increases your chances of skin cancer so the sooner you start avoiding skin cancer the better. Here are a few things you can start acting on, in order to immediately start reducing your risk of getting skin cancer:

Rodman & Renshaw Presentation Overview

This week, our CEO, Punit Dhillon, presented at the 15th Annual Rodman & Renshaw Global Investment Conference. The annual event hosted over 150 established and emerging biotech and pharmaceutical companies. During the presentation, Mr. Dhillon reviewed previous data points and provided an update on upcoming milestones. Here is an overview of the presentation:

OncoSec’s “What We’re Reading”: Volume 2

Each week at OncoSec, we come across a wide range of news material. This week, we continue our “What We’re Reading” series, with our second instalment. There have been quite a number of recent articles regarding cancer, the biotech industry and treatment methods but we would like to highlight three that you might find interesting and informative.

Why does OncoSec use Immunotherapy?

In biotech, there are many different approaches or veins of science used, in the research and creation of potential treatments, drugs, and delivery methods. For centuries, the health industry has relied on invasive surgery and curative procedures that can have dangerous, long-term side effects for patients. However, there are some newer scientific discoveries that have allowed us to move towards more effective treatment options that are also less damaging to our bodies. One of these categories of research is that of immunotherapy: using the body against disease, instead of relying on as many non-targeted, exterior factors.

Clinical Trials, Data, and Staging

The biotech and medical industries have come a long way. While many marvels have been created – such as vaccines, treatments and prosthetics – some of the research could pose dangers to the public, if it is not used correctly or if the initial findings from early experimentation are wrong. It is for these reasons that the FDA requires proper clinical testing (or clinical trials) to be performed, before they are eligible for public use. We would like to explore what exactly a clinical trial is, the data they collect and how a clinical trial moves on to the next phase:

What is ImmunoPulse?

Many cancer research and treatment companies create and utilize various methods of treatment. These may be a combination of existing techniques or a new technology developed by the company itself. At OncoSec, one of our treatment methods is ImmunoPulse: a system we’re testing for the treatment of late-stage skin cancer, including merkel cell carcinoma, cutaneous T-cell lymphoma, and metastatic melanoma. With pending announcements surrounding interim data from our phase II trial for metastatic melanoma coming up soon, we would like to review a bit of the description of our ImmunoPulse treatment option currently being tested.


1 2 3 4
Real Time Web Analytics